October 24, 2024 Sophia Vida
Breaking News

Soligenix, Inc. to Present at the 2024 ThinkEquity Conference

Princeton, NJ, October 24, 2024 – PRISM MediaWire – Soligenix, Inc. (Nasdaq: SNGX) (“Soligenix” or the “Company”) a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the … Continue reading “Soligenix, Inc. to Present at the 2024 ThinkEquity Conference”